Blinatumomab Plus Reduced-dose Chemotherapy in Treating B-ALL
NCT06742515
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Precursor B-Cell Acute Lymphoblastic Leukemia
Interventions
DRUG:
Blinatumomab plus Reduced-dose Chemotherapy
Sponsor
First Affiliated Hospital of Zhejiang University